Chemistry Cost per Reportable Result (CPRR), Equipment and Reagents HT940825QE009
Summary
AI-generated · Sep 13, 2025Perform chemistry and special chemistry testing for Keesler Medical Center (Keesler AFB) under a cost-per-reportable-result arrangement where Siemens Healthcare Diagnostics will supply and maintain all needed analyzers, equipment, reagents, consumables, and related services. The award is intended to be a sole-source, firm-fixed-price contract under the CPRR vehicle; the contractor must deliver, install, and validate the analyzer(s) to ensure patient-ready testing and provide connectivity to the Defense Health Agency/Military Health System network for confirmed operation during the initial delivery period, with option periods to extend the agreement.
Interested sources may submit a capability statement showing the ability to perform the required testing, deliver/install/validate the necessary analyzer(s), and establish network connectivity to DHA/MHS. The government will consider capability statements but will not reimburse the submission of information; no telephonic inquiries or capability briefings will be honored, and the decision not to compete will be at the government’s discretion. Responses must be received by the stated deadline.
The Healthcare Contracting Division South (HCD-S), San Antonio, Texas, intends to award a firm-fixed-price (FFP) sole source contract to Siemens Healthcare Diagnostics of Tarrytown, New York to conduct Chemistry and Special Chemistry testing for Keesler Medical Center, Keesler Air Force Base, Mississippi. As a Cost-per-Reportable-Result (CPRR) vehicle, the contractor also provides all equipment, consumables, and services necessary to perform the required testing. The contract will be awarded under the authority of Federal Acquisition Regulation (FAR) 13.501. The applicable NAICS code for this requirement is 325413, In-Vitro Diagnostics Substance Manufacturing. The Small Business Size Standard is 1,250 employees. Siemens Healthcare Diagnostics is an "other-than-small business." The contract will be awarded on or before 1 October 2025. NOTE: This contract will be issued for a delivery period of 1 October 2025 -31 March 2026, with two (2) two-month option periods through 31 July 2026. This notice is not a request for competitive quotes. All responsible sources may submit a capability statement, which shall be considered by the agency before the intended award date to determine if any other entity is capable of performing the required testing. Interested sources who submit data are responsible for appropriately marking information if it is proprietary in nature. In order for the Government to consider another source, the capability statement must demonstrate the source's ability to 1) provide the required testing; 2) deliver, install, and validate the analyzer(s) to ensure patient-ready testing by 01 October 2025; and 3) ability to connect to the Defense Health Agency/Military Health System network. The Government shall not reimburse interested sources for any information provided. No requests for capability briefings will be honored as a result of this notice and any information provided will not be used as part of any subsequent solicitation requirement. No telephonic inquires will be honored. A determination by the Government not to compete with this proposed contract based upon responses to this notice is solely within the discretion of the Government. NOTE: INTERESTED VENDORS MUST RESPOND TO THIS NOTICE TO THE BELOW POCs ON OR BEFORE 12 SEPTEMBER 2025 BY 10 AM CENTRAL TIME IN ORDER TO BE CONSIDERED.
From Special Notice posted on Sep 10, 2025Notice history
1-
Special Notice LATEST Posted Sep 10, 2025
Details
Award Information
Not yet awarded
Contacts
Phone
Agency
Place of Performance
USA